Vimeo
LinkedIn
Instagram
Share |

medtech

April 28, 2020

The coronavirus pandemic has triggered a race for disruptive innovation in diagnostics, new therapies and novel vaccines, but the global life sciences industry was already expected to reach more than $2 trillion in gross value by 2023, up from $1.6 trillion before the crisis.

The coronavirus pandemic has triggered a race for disruptive innovation in diagnostics, new therapies and novel vaccines, but the global life sciences industry was already expected to reach more than $2 trillion in gross value by 2023, up from $1.6 trillion before the crisis.

February 6, 2020

Devices to beat hospital-acquired infections, prevent opioid overdoses and instantly spot infections in blood are among the pioneering healthcare innovations being showcased to family investors at the upcoming MedTech Investing Europe Conference in Lausanne.

Devices to beat hospital-acquired infections, prevent opioid overdoses and instantly spot infections in blood are among the pioneering healthcare innovations being showcased to family investors at the upcoming MedTech Investing Europe Conference in Lausanne.

August 16, 2016

Despite a reputation for being high-risk, the MedTech sector boasts above-average historical returns, strong returns on capital, and innovations that can improve quality of life. CampdenFO looks at three families that have ‘hit the vein’

Despite a reputation for being high-risk, the MedTech sector boasts above-average historical returns, strong returns on capital, and innovations that can improve quality of life. CampdenFO looks at three families that have ‘hit the vein’

November 20, 2015

The MedTech sector is a maze of innovations that ranges from syringes to software. xxCampdenFOxx looks at how families are investing and flags five early-stage companies to watch

It could be an app, or it could be an autoinjector - there are more than 500,000 medical technologies seeking to innovate, or distribute, in the healthcare industry.

Click here >>
Close